Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding AG    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees : 97 735 people.
Sales per Business
20182019Delta
CHF (in Million)%CHF (in Million)%
Pharmaceuticals46,52081.8%50,71482.5% +9.02%
Diagnostics12,97722.8%13,03721.2% +0.46%
Sales per region
20182019Delta
CHF (in Million)%CHF (in Million)%
United States28,08149.4%31,16450.7% +10.98%
Rest of Europe9,84217.3%9,67215.7% -1.73%
Rest of Asia7,70513.6%8,71714.2% +13.13%
Japan4,4907.9%4,6747.6% +4.1%
Germany3,1795.6%3,0845% -2.99%
Latin America2,8705%2,8584.6% -0.42%
Africa, Australia and Oceania1,4742.6%1,3592.2% -7.8%
Switzerland924.001.6%1,2372% +33.87%
Rest of North America932.001.6%986.001.6% +5.79%
Managers and Directors
NameAgeSinceTitle
Severin Schwan532015Chief Executive Officer & Executive Director
Christoph Franz602014Chairman
Alan Hippe, Dr.692011Chief Financial & Information Technology Officer
Paul Bulcke652012Non-Executive Director
André S. Hoffmann612012Vice Chairman
Bernard J. Poussot682015Non-Executive Director
Richard P. Lifton, Dr.672015Non-Executive Director
Claudia Süssmuth Dyckerhoff, Dr.532016Director
Julie Brown582016Director
Anita Hauser512017Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 702,562,700 694,641,595 98.9% 7,921,105 1.1% 83.6%
Stock B 1 160,000,000 26,314,116 16.4% 0 0.0%
Shareholders
NameEquities%
The Vanguard Group, Inc. 20,970,555 2.98%
Norges Bank Investment Management 19,422,629 2.76%
Fidelity Management & Research Co. LLC 14,596,113 2.08%
UBS Asset Management Switzerland AG 11,490,139 1.64%
BlackRock Fund Advisors 10,807,734 1.54%
Credit Suisse Asset Management (Schweiz) AG 8,754,247 1.25%
Massachusetts Financial Services Co. 7,312,199 1.04%
Zürcher Kantonalbank (Investment Management) 7,186,115 1.02%
Roche Holding AG 6,800,000 0.97%
PRIMECAP Management Co. 5,560,379 0.79%
Holdings
NameEquities%Valuation
Chugai Pharmaceutical Co., Ltd. (4519) 1,005,669,00059.9%53,602,559,968 USD
Roche Holding AG (ROG) 6,800,0000.97%2,379,884,468 USD
Aligos Therapeutics, Inc. (ALGS) 3,092,3408.11%85,503,201 USD
Pandion Therapeutics, Inc. (PAND) 3,086,08410.5%45,828,347 USD
Senseonics Holdings, Inc. (SENS) 28,345,27611.5%24,717,081 USD
Millendo Therapeutics, Inc. (MLND) 1,089,1805.73%2,330,845 USD
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : http://www.roche.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Roche Holding AG
Sector Pharmaceuticals - NEC